Clinical Trial

INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen

Study acronym: INSPIRE-Pilot
Completed
View on ClinicalTrials.gov →
Summary
High-flow nasal oxygen (HFNO) is recommended as first-line treatment to prevent intubation in acute hypoxemic respiratory failure and to prevent reintubation after extubation. Accumulating data suggest that strong inspiratory efforts and their persistence are associated with HFNO failure. However, tools to monitor continuously and noninvasively inspiratory efforts are lacking. The investigators have developed an algorithm estimating noninvasively inspiratory efforts under HFNO. This pilot study aims at testing the feasibility of estimating inspiratory efforts in patients treated with HNFO.
Protocol Amendment History 1 change
critical Trial completed 2026-04-15
Trial Details
NCT Number NCT07228676
Lead Sponsor Poitiers University Hospital
Conditions Oxygen, Respiratory Insufficiency, Work of Breathing, Dyspnea
Enrollment 20 participants
Start Date 2025-11-29
Primary Completion 2026-03-13 (estimated)
Study Completion 2026-04-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-22